Search filters

List of works by Anna Maria Malfitano

1,2-Dihydro-2-oxopyridine-3-carboxamides: The C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor

scientific article published on 21 January 2014

Anandamide inhibits adhesion and migration of breast cancer cells

scientific article published on 15 December 2005

Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells

scientific article published on 21 February 2013

Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation.

scientific article

Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells

scientific article published on 05 March 2007

Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis

scientific article published on 18 October 2005

Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drug

scientific article published on February 2008

Breast adiponcosis: a call for further research

scientific article published on 04 January 2016

Cannabidiol: State of the art and new challenges for therapeutic applications

scientific article published on 20 February 2017

Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders

scientific article published on 19 June 2016

Cannabinoid receptor CB1 antagonists state of the art and challenges.

scientific article published on January 2009

Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells

scientific article

Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response

scientific article published on 19 June 2016

Cannabinoids in the management of spasticity associated with multiple sclerosis.

scientific article published on October 2008

Characterization of linear mimetic peptides of Interleukin-22 from dissection of protein interfaces.

scientific article

Comment on "the negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia.".

scientific article published in March 2015

Editorial (Thematic Issue: From Old Cannabinoids to Emerging New Synthetic Derivatives with Potential Therapeutic Application in Neurological Disorders)

scientific article published on 01 January 2016

Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis

scientific article

Endocannabinoid System in Neurological Disorders.

scientific article published on 27 June 2016

From anecdotal evidence of cannabinoids in multiple sclerosis to emerging new therapeutical approaches

scientific article published on 01 January 2007

From cannabis to endocannabinoids in multiple sclerosis: a paradigm of central nervous system autoimmune diseases.

scientific article

G-Quadruplex Binders Induce Immunogenic Cell Death Markers in Aggressive Breast Cancer Cells

scientific article published on 15 November 2019

Immune-modulation and properties of absorption and blood brain barrier permeability of 1,8-naphthyridine derivatives

scientific article published in October 2013

Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple Sclerosis.

scientific article

Immuno-Modulatory and Anti-Inflammatory Effects of Dihydrogracilin A, a Terpene Derived from the Marine Sponge Dendrilla membranosa

scientific article

Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15.

scientific article published on 17 February 2017

Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells.

scientific article published on 18 May 2010

Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth.

scientific article published on January 2012

Interactions of cisplatin analogues with lysozyme: a comparative analysis

scientific article published on 14 August 2017

Involvement of Akt/NF-κB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cells.

scientific article published on October 2010

Molecular signaling involving intrinsically disordered proteins in prostate cancer

scientific article

N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice.

scientific article

N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A.

scientific article published on 18 November 2013

N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation.

scientific article published on 11 July 2013

New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity

scientific article published on 24 April 2015

Nucleophosmin-1 regions associated with acute myeloid leukemia interact differently with lipid membranes.

scientific article published on 9 January 2018

Oxylipins from Dracontium loretense.

scientific article

Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer

scientific article published on November 21, 2011

Pharmacological Inhibition of WEE1 Potentiates the Antitumoral Effect of the dl922-947 Oncolytic Virus in Malignant Mesothelioma Cell Lines

scientific article published on 04 October 2020

Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders

scientific article published on 17 May 2016

Potential therapeutic role of statins in neurological disorders.

scientific article published on May 2008

Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold.

scientific article

Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon.

scientific article published in September 2009

Statins in neurological disorders: an overview and update.

scientific article

Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2',3'-cyclic nucleotide-3'-phosphodiesterase

scientific article published on 13 December 2007

Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin.

scientific article

The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice.

scientific article

The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism

scientific article published on 5 July 2006

Tumor-Associated Macrophage Status in Cancer Treatment

scientific article published on 21 July 2020

Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents.

scientific article published on February 2009

What we know and do not know about the cannabinoid receptor 2 (CB2)

scientific article

p53 regulates the mevalonate pathway in human glioblastoma multiforme.

scientific article